Cargando…
The Use of Sensitive Chemical Antibodies for Diagnosis: Detection of Low Levels of Epcam in Breast Cancer
EpCAM is expressed at low levels in a variety of normal human epithelial tissues, but is overexpressed in 70–90% of carcinomas. From a clinico-pathological point of view, this has both prognostic and therapeutic significance. EpCAM was first suggested as a therapeutic target for the treatment of epi...
Autores principales: | Shigdar, Sarah, Qian, Christine, Lv, Li, Pu, Chunwen, Li, Yong, Li, Lianhong, Marappan, Manju, Lin, Jia, Wang, Lifen, Duan, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584034/ https://www.ncbi.nlm.nih.gov/pubmed/23460885 http://dx.doi.org/10.1371/journal.pone.0057613 |
Ejemplares similares
-
Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors
por: Xiang, Dongxi, et al.
Publicado: (2015) -
EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model
por: Wang, Tao, et al.
Publicado: (2015) -
EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs
por: Macdonald, Joanna, et al.
Publicado: (2018) -
Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo
por: Xiang, Dongxi, et al.
Publicado: (2013) -
Nucleic Acid Aptamer-Guided Cancer Therapeutics and Diagnostics: the Next Generation of Cancer Medicine
por: Xiang, Dongxi, et al.
Publicado: (2015)